RYSE Asset Management
Seed and Series A investor in healthtech, including digital diagnostics and therapeutics
- Venture capital
- London
- Type
- Venture capital
- Based in
- London
- Stages
- Pre-seed, Seed, Series A, Series B+
- Sector focus
- Fintech, Insurtech
- Cheque size
- €100k–€1.5M
- Fund size
- Undisclosed
- Founded
- 2017
- Website
- ryseam.com
RYSE Asset Management is a London venture capital firm focused on health technology. Its areas of interest include digital diagnostics, digital therapeutics, medical devices and AI applied to healthcare.
The firm says it was founded in 2017 and invests at seed and Series A stage. Its portfolio includes Curio Digital Therapeutics, and it has announced a first close for a Special Opportunities Fund, without disclosing the amount raised.
← All investors · Is this your organisation? Request an update
More investors in the directory
The Craftory
Purpose-driven consumer packaged goods brands with category-changing potential
Symvan Capital
EIS and SEIS funds backing B2B SaaS and technology companies from seed to exit
Grafton Capital
Growth capital for European software, AI and tech-enabled businesses
Blackfinch Ventures
EIS and VCT investment in early and growth-stage UK technology businesses
The Conduit Connect
Impact-led UK startups from pre-seed to Series A in climate, health and financial resilience
TrueSight Ventures
Angel-sized cheques at pre-seed and seed, sector-agnostic, into technology companies
Subscribe to Newsletter
Join me on this exciting journey as we explore the boundless world of web design together.